Lupin Kicks Off 2024 With Major US Generics Launches
Introduces Rival To Prolensa With 180-Day Exclusivity And Challenges Chantix
Lupin has begun 2024 by notching up multiple US approvals and launches, including introducing an exclusive generic version of Prolensa and challenging Chantix.
